Clinical Trial Update: Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating methylprednisolone pulses and tacrolimus in patients with COVID-19-related lung injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Methylprednisolone pulses (methylprednisolone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: COVID-19, Lung Injury | Phase 3 | Status: UNKNOWN